Full Press Release Details
MILESTONE SCIENTIFIC EXPANDS U.S. AND CANADIAN DISTRIBUTION
NETWORK WITH ADDITION OF PATTERSON DENTAL SUPPLY
LIVINGSTON, N.J. (PR NEWSWIRE) June 5, 2008 Milestone Scientific Inc. (OTCBB:MLSS), the
recognized leader in advanced injection technologies, today announced that it has expanded its U.S.
and Canadian distribution network with the addition of Patterson Dental Supply, a division of
Patterson Companies, Inc. (Nasdaq:PDCO).
Patterson Dental Supply has the largest direct sales force in the industry, totaling approximately
1,400 sales representatives and equipment/software specialists serving the United States and
Canada. Patterson will join Henry Schein, Inc. (Nasdaq:HSIC), the largest distributor of
healthcare products and services to office-based practitioners in the combined North American and
European markets, to both market and sell on a non-exclusive basis the STA System,
Milestone s patented, award-winning, painless dental injection solution, and related disposable
hand pieces to dental professionals in the United States and Canada.
Joe Martin, Chief Executive Officer of Milestone, stated By leveraging the marketing muscle,
reputational reach and influence of the two largest dental suppliers in the industry, Milestone
looks forward to achieving the market penetration necessary to drive broad adoption of the STA
System as the new standard of care for dental injections. Moreover, as we persist in building our
global distribution network, the further addition of strategic distribution partners in key
international markets will aid us in promoting potentially profound sales growth from the worldwide
marketing of the STA System. We are very pleased to welcome the Patterson organization to our team
and appreciate that they share our enthusiasm and expectations for Milestone and our innovative
technological solutions.
The state-of-the-art STA System is Milestone s latest achievement in computer-controlled local
anesthesia delivery (CCLAD) that makes the injection process more comfortable for both dentists and
patients. Marketed for use by dental practitioners to painlessly administer all dental injections,
the STA System is uniquely capable of administering Single Tooth Anesthesia into the Periodontal
Intraligamentary (PDL) space, something never before possible using conventional techniques.
About Patterson Companies, Inc.
Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet
veterinarian and rehabilitation supply markets.
As Patterson s largest business, Patterson Dental provides a virtually complete range of consumable
dental products, equipment and software, turnkey digital solutions and value-added services to
dentists and dental laboratories throughout North America.
Webster Veterinary is the nation s second largest distributor of consumable veterinary supplies,
equipment and software, diagnostic products, vaccines and pharmaceuticals to companion-pet
Rehabilitation Market
Patterson Medical is the world s leading distributor of rehabilitation supplies and non-wheelchair
assistive patient products to the physical and occupational therapy markets. The unit s global
customer base includes hospitals, long-term care facilities, clinics and dealers.
About Henry Schein, Inc.
Henry Schein, a Fortune 500 company and a member of the NASDAQ 100 Index,
is recognized for its excellent customer service and highly competitive prices. The Company s four
business groups Dental, Medical, International and Technology serve more than 550,000 customers
worldwide, including dental practitioners and laboratories, physician practices and animal health
clinics, as well as government and other institutions. The Company operates through a centralized
and automated distribution network, which provides customers in more than 200 countries with a
comprehensive selection of more than 90,000 national and Henry Schein private-brand products in
stock, as well as more than 100,000 additional products available as special-order items.
Headquartered in Melville, N.Y., Henry Schein employs over 12,000 people and has operations or
affiliates in 20 countries. The Company s net sales reached a record $5.9 billion in 2007. For more
information, visit the Henry Schein Web site at www.henryschein.com.
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary,
highly innovative technological solutions for the medical and dental markets. Central to the
Company s IP platform and product development strategy is its patented CompuFlo
technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a
computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology,
which provides real-time readouts of pressures, fluid densities and flow rates, enabling the
advanced delivery and removal of a wide array of fluids. The STA (Single Tooth
Anesthesia) System computer-controlled local anesthesia delivery system which uses this technology
provides dentists with audible and visual signals as to in-tissue pressure. Milestone s existing
painless injection systems are currently sold in 25 countries. For more information on these and
other innovative Milestone products, please visit the Company s Web sites found at www.milesci.com
and www.STAis4U.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of
the Milestone s ability to implement its business plan, expected revenues and future success. These
statements involve a number of risks and uncertainties and are based on assumptions involving
judgments with respect to future economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict accurately and many of which are
beyond Milestone s control. Some of the important factors that could cause actual results to differ
materially from those indicated by the forward-looking statements are general economic conditions,
failure to achieve expected revenue growth, changes in our operating expenses, adverse patent
rulings, FDA or legal developments, competitive pressures, changes in customer and market
requirements and standards, and the risk factors detailed from time to time in Milestone s periodic
filings with the Securities and Exchange Commission, including without limitation, Milestone s
Annual Report on Form 10-KSB for the year ended December 31, 2007. The forward looking-statements
in this press release are based upon management s reasonable belief as of the date hereof.
Milestone undertakes no obligation to revise or update publicly any forward-looking statements for
FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group/Elite Media Group
Dodi Handy, President and CEO
407-585-1080 or via email at mlss@efcg.net